trending Market Intelligence /marketintelligence/en/news-insights/trending/ya6qg4peptv8flh8jgpcwg2 content esgSubNav
In This List

UniQure appoints 2 board members

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond


UniQure appoints 2 board members

Amsterdam-based gene therapy company uniQure NV appointed Robert Gut and David Meek to the board.

Gut is currently the chief medical officer for Versartis Inc. Meek has been the CEO of Ipsen SA since 2016.